News
MPHMF
0.013
NaN%
--
Weekly Report: what happened at MPHMF last week (0908-0912)?
Weekly Report · 09/15 10:11
Weekly Report: what happened at MPHMF last week (0901-0905)?
Weekly Report · 09/08 10:12
Weekly Report: what happened at MPHMF last week (0825-0829)?
Weekly Report · 09/01 10:10
Weekly Report: what happened at MPHMF last week (0818-0822)?
Weekly Report · 08/25 10:15
Weekly Report: what happened at MPHMF last week (0811-0815)?
Weekly Report · 08/18 10:11
Weekly Report: what happened at MPHMF last week (0804-0808)?
Weekly Report · 08/11 10:14
Weekly Report: what happened at MPHMF last week (0728-0801)?
Weekly Report · 08/04 10:16
Weekly Report: what happened at MPHMF last week (0721-0725)?
Weekly Report · 07/28 10:17
Weekly Report: what happened at MPHMF last week (0714-0718)?
Weekly Report · 07/21 10:11
Weekly Report: what happened at MPHMF last week (0707-0711)?
Weekly Report · 07/14 10:16
Weekly Report: what happened at MPHMF last week (0630-0704)?
Weekly Report · 07/07 10:12
Weekly Report: what happened at MPHMF last week (0623-0627)?
Weekly Report · 06/30 10:15
Weekly Report: what happened at MPHMF last week (0616-0620)?
Weekly Report · 06/23 10:12
Weekly Report: what happened at MPHMF last week (0609-0613)?
Weekly Report · 06/16 10:15
Weekly Report: what happened at MPHMF last week (0602-0606)?
Weekly Report · 06/09 10:16
Weekly Report: what happened at MPHMF last week (0526-0530)?
Weekly Report · 06/02 10:20
Weekly Report: what happened at MPHMF last week (0519-0523)?
Weekly Report · 05/26 10:20
Weekly Report: what happened at MPHMF last week (0512-0516)?
Weekly Report · 05/19 10:15
Weekly Report: what happened at MPHMF last week (0505-0509)?
Weekly Report · 05/12 10:16
Weekly Report: what happened at MPHMF last week (0428-0502)?
Weekly Report · 05/05 10:16
More
Webull provides a variety of real-time MPHMF stock news. You can receive the latest news about Callitas Health through multiple platforms. This information may help you make smarter investment decisions.
About MPHMF
Callitas Health Inc. is a clinical-stage pharmaceutical development, over-the-counter (OTC) consumer goods marketing and cannabis delivery development company. The Company is focused on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. Its pharmaceutical/research and development pipeline includes C-103, which is a reformulation of Xenical (Orlistat 120 mg) for the treatment of obesity which minimizes adverse side effects associated with the use of Xenical, and Extrinsa, is a topical prescription gel that increases vaginal blood flow addressing female sexual dysfunction (FSD) issues. Extrinsa uses a combination of menthol/L-arginine and tadalafil (a PD5 inhibitor).